| Has payment by results affected the way that English hospitals provide care? Difference-in-differences analysis S Farrar, D Yi, M Sutton, M Chalkley, J Sussex, A Scott Bmj 339, 2009 | 261 | 2009 |
| The R&D cost of a new medicine J Mestre-Ferrandiz, J Sussex, A Towse Monograph, 2012 | 236 | 2012 |
| How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice SR Hanney, S Castle-Clarke, J Grant, S Guthrie, C Henshall, ... Health research policy and systems 13, 1-18, 2015 | 209 | 2015 |
| Incorporating multiple criteria in HTA N Devlin, J Sussex Methods and processes. London, 2011 | 182 | 2011 |
| The trajectory of dementia in the UK-making a difference F Lewis, S Karlsberg Schaffer, J Sussex, P O’Neill, L Cockcroft Office of Health Economics Consulting Reports 2013, 1-55, 2014 | 138 | 2014 |
| Operationalizing value-based pricing of medicines: a taxonomy of approaches J Sussex, A Towse, N Devlin Pharmacoeconomics 31 (1), 1-10, 2013 | 133 | 2013 |
| A pilot study of multicriteria decision analysis for valuing orphan medicines J Sussex, P Rollet, M Garau, C Schmitt, A Kent, A Hutchings Value in Health 16 (8), 1163-1169, 2013 | 130 | 2013 |
| From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons? SR Hanney, S Wooding, J Sussex, J Grant Health Research Policy and Systems 18, 1-10, 2020 | 92 | 2020 |
| The economics of the private finance initiative in the NHS J Sussex Office of Health Economics, 2001 | 81 | 2001 |
| Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom J Sussex, Y Feng, J Mestre-Ferrandiz, M Pistollato, M Hafner, P Burridge, ... BMC medicine 14, 1-23, 2016 | 79 | 2016 |
| Prioritizing health technologies in a Primary Care Trust E Wilson, J Sussex, C Macleod, R Fordham Journal of Health Services Research & Policy 12 (2), 80-85, 2007 | 56 | 2007 |
| Medical Research: What’s it worth? Estimating the economic benefits from medical research in the UK M Buxton, S Hanney, S Morris, L Sundmacher, J Mestre-Ferrandiz, ... London: UK Evaluation Forum (Academy of Medical Sciences, MRC, Wellcome …, 2008 | 54 | 2008 |
| Medical Research: What’s it worth? Estimating the economic benefits from medical research in the UK M Buxton, S Hanney, S Morris, L Sundmacher, J Mestre-Ferrandiz, ... London: UK Evaluation Forum (Academy of Medical Sciences, MRC, Wellcome …, 2008 | 54 | 2008 |
| National evaluation of payment by results S Farrar, J Sussex, D Yi, M Sutton, M Chalkley, T Scott, A Ma Health Economics Research Unit, 95-105, 2007 | 42 | 2007 |
| Is the aim of the English health care system to maximize QALYs? K Shah, C Praet, N Devlin, J Sussex, J Appleby, D Parkin Journal of Health Services Research & Policy 17 (3), 157-163, 2012 | 40 | 2012 |
| Critique of CHE research paper 81: methods for the estimation of the NICE cost effectiveness threshold P Barnsley, A Towse, J Sussex Sarah and Sussex, Jonathan Mark, Critique of CHE Research Paper 81, 2013 | 37 | 2013 |
| Opportunity costs and local health service spending decisions: a qualitative study from Wales S Karlsberg Schaffer, J Sussex, D Hughes, N Devlin BMC health services research 16, 1-13, 2016 | 33 | 2016 |
| Multi-criteria decision analysis to value orphan medicines J Sussex, P Rollet, M Garau, C Schmitt, A Kent, A Hutchings OHE Research Paper 13 (03), 2013 | 33 | 2013 |
| “Getting UK health care expenditure up to the European Union mean”—what does that mean? A Towse, J Sussex BMJ 320 (7235), 640-642, 2000 | 33 | 2000 |
| Public-private partnerships in hospital development: lessons from the UK'sprivate finance initiative'. J Sussex Research in Healthcare Financial Management 8 (1), 59-77, 2003 | 31 | 2003 |
